Sera Labs, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Sera Labs, Inc. - overview

Established

2018

Location

Lewiston, ME, US

Primary Industry

Internet

About

Sera Labs, Inc. is a health and wellness company specializing in innovative products that leverage clean, plant-based ingredients and advanced delivery systems to enhance skincare and overall health. Founded in 2018 and headquartered in Lewiston, US, Sera Labs, Inc. focuses on health and wellness innovations.


The company has successfully completed two deals and was acquired by Cure Pharmaceutical Holding Corp. in September 2020 for USD 20 mn. Nancy Duitch serves as both the CEO and founder of Sera Labs, and she has a history of entrepreneurial ventures. Sera Labs specializes in innovative health and wellness products that combine clean, plant-based ingredients with advanced delivery systems.


Their core product offerings include the Seratopical Revolution serum, which utilizes Deep Nano Actives to deliver active ingredients deep into the skin layers, effectively reducing the appearance of fine lines and wrinkles in as little as two minutes. Additionally, their Nutri-Strips provide a convenient alternative to traditional supplements, dissolving on the tongue to offer all-natural solutions for improved sleep, energy, and post-workout recovery. These products are designed for a diverse client base, including consumers seeking effective skincare solutions and those looking for holistic health support. Sera Labs markets its products primarily in North America, with a growing presence in other international markets, aiming to cater to health-conscious individuals globally.


Sera Labs operates a direct-to-consumer sales model, facilitating transactions through their online platform. They generate revenue from the sale of their flagship products, including the Seratopical Revolution serum and Nutri-Strips, which are marketed as premium health and skincare solutions. Customers can take advantage of promotional offers, such as a discount on their first order, encouraging initial purchases. The company’s pricing structure reflects the premium nature of its product offerings, with individual items available for direct purchase.


This model enables Sera Labs to maintain control over brand positioning and customer experience, fostering direct relationships with consumers. Sera Labs is focused on expanding its product line with upcoming innovations in health and wellness solutions. Following the acquisition in September 2020, the company has plans to utilize the USD 20 mn funding for product development and market expansion. They aim to enter new geographic regions, specifically targeting growth in international markets by 2023.


The company is actively designing new products that will enhance their current offerings, further solidifying their market presence.


Primary Industry

Internet

Sub Industries

Pet Products, Beauty & Hygiene, Snack Foods, Search Engines, Medicinal Chemicals & Botanicals

Website

www.seralabshealth.com

Verticals

Cannabis/Medical Marijuana, E-commerce

Company Stage

Acquired

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.